Chun Y — Endo Lab

2024

Assessing the New 2020 ESGO/ESTRO/ESP Endometrial Cancer Risk Molecular Categorization System for Predicting Survival and Recurrence.

Cancers ·doi:10.3390/cancers16050965

This study aimed to evaluate the efficacy of the 2020 European Society of Gynecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology (ESGO/ESTRO/ESP) guidelines for endometrial cancer (EC). Additiona…

2023

Clear Cell Borderline Tumor of the Ovary: A Case Report.

Journal of the Korean Society of Radiology ·doi:10.3348/jksr.2022.0118

Clear cell borderline ovarian tumor (CCBOT) is quite rare, and only a few cases of CCBOT have been reported. Unlike most borderline ovarian tumors, CCBOTs appear solid because they are almost always pathologically adenofibromatous. Herein, …

2023

Radiologic Findings of Mesonephric-Like Adenocarcinoma of the Uterine Corpus: A Case Report.

Journal of the Korean Society of Radiology ·doi:10.3348/jksr.2022.0119

According to the 2020 World Health Organization classification, mesonephric-like adenocarcinoma (MLA) is newly categorized as a subtype of endometrial carcinoma and remains a relatively unknown disease owing to its rarity. To the best of ou…